It is a pharma private limited company based in New Delhi, Delhi, India, established in 2018.
2018 | New Delhi, Delhi, India | ActiveIlios Pharma Private Limited, a active private limited company, was established on 14 June 2018 in New Delhi, Delhi, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24304DL2018PTC335293. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.10 M.
Its leadership includes Vipin Kumar (Director), Ramjanki Swarnkar (Director), Kamya Verma (Director). Past directors included Vimlesh, Kamya Verma, Prabha Devi Soni. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 304 Corner, T/F Floor, Plot No-1 Harsha Complex, Dda, Lsc, Gazipur, New Delhi, Delhi, 110092.
U24304DL2018PTC335293
335293
14 June 2018
₹0.50 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Ilios Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vipin Kumar | Director | 14 Jun 2018 | Current |
| Ramjanki Swarnkar | Director | 14 Jun 2018 | Current |
| Kamya Verma | Director | 27 Jul 2018 | Current |
| Prabha Devi Soni | Director | 27 Jul 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 22 Dec 2018 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2019 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Ilios Pharma Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 301.54% increase. The company also saw a substantial improvement in profitability, with a 668.77% increase in profit. The company's net worth Soared by an impressive increase of 76.68%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Ilios Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Ilios Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Ilios Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ilios Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Ilios Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.
Progress on Ilios Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was documented.
Kamya Verma was appointed as a Director was appointed as a Director on 27 Jul 2018 & has been associated with this company since 7 years 4 months . was recorded as a recent event.
The activity Prabha Devi Soni was appointed as a Director was appointed as a Director on 27 Jul 2018 & has been associated with this company since 7 years 4 months . was completed.
The activity Vipin Kumar was appointed as a Director was appointed as a Director on 14 Jun 2018 & has been associated with this company since 7 years 6 months . was completed.
Ramjanki Swarnkar was appointed as a Director was appointed as a Director on 14 Jun 2018 & has been associated with this company since 7 years 6 months . was recorded as a recent event.
The CIN of Ilios Pharma Private Limited is U24304DL2018PTC335293.
Ilios Pharma Private Limited is headquartered at 304 Corner, T/F Floor, Plot No-1 Harsha Complex, Dda, Lsc, Gazipur, New Delhi, Delhi, 110092.
Ilios Pharma Private Limited was incorporated on 14 June 2018.
The current directors of Ilios Pharma Private Limited are
The primary industry of Ilios Pharma Private Limited is Pharma.
Ilios Pharma Private Limited is unlisted.
The authorized capital of Ilios Pharma Private Limited is ₹0.50 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX